Postoperative Results After Patient Blood Management with Intravenous Iron Treatment Implementation for Preoperative Anemia: Prospective Cohort Study of 1294 Colorectal Cancer Patients
Open Access
Abstract
Background: PA is frequent in CRC patients and known to be detrimental to surgical outcomes. PBM systems promote rational use of blood products and PA treatment with IVI, which could potentially improve postoperative results and the need for RBCT. Objective: To evaluate the effectiveness of Intravenous Iron (IVI) within a Patient Blood Management (PBM) pathway in Colorectal Cancer (CRC) patients with Preoperative Anemia (PA). To analyze surgical results after treatment and the need for Red Blood Cell Transfusion (RBCT) after surgery. Methods: Cohort study of CRC patients between 2012 and 2018, divided into groups: non-anemic patients (Hemoglobin Hb > 13 g/dL, Group 1), mildly anemic patients (Hb 12–13 mg/dL, Group 2), and patients treated with IVI (Hb < 12 mg/dL or Hb 12–13 mg/dL with risk factors, Group 3). Effectiveness of IVI treatment measured based on differences in Hb changes. Surgical complications were assessed and compared among groups, as well as the RBCT rate. The latter was also compared between Group 3 patients and those receiving preoperative RBCT. Results: Group 3 presented with a baseline Hb of 9.9 (±1.5) mg/dL with an increase of 1.2 (±1.9) mg/dL after treatment, which endured until discharge. Clavien-Dindo III-IV complications were 6.5%, and 30-day Mortality was 1.4% in all the series, without differences among Groups. RBCT rate in Group 3 patients was 21.6%, significantly lower than that of patients receiving preoperative RBCT (32.6%). Conclusions: IVI is a safe and effective measure for a fast PA correction in CCR patients and could potentially reduce postoperative RBCT rates.Keywords
This publication has 34 references indexed in Scilit:
- Preoperative Intravenous Iron Treatment in Colorectal Cancer: Experience From Clinical PracticeJournal of Surgical Research, 2022
- Blood transfusion has an adverse impact on the prognosis of patients receiving chemotherapy for advanced colorectal cancer: experience from a single institution with a patient blood management programSupportive Care in Cancer, 2022
- Patient blood management interventions do not lead to important clinical benefits or cost-effectiveness for major surgery: a network meta-analysisBritish Journal of Anaesthesia, 2021
- Use of intravenous iron therapy in colorectal cancer patient with iron deficiency anemia: a propensity-score matched studyInternational Journal of Colorectal Disease, 2020
- Randomized clinical trial of preoperative oral versus intravenous iron in anaemic patients with colorectal cancerBritish Journal of Surgery, 2017
- Patient blood management equals patient safetyBest Practice & Research Clinical Anaesthesiology, 2016
- Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemiaInternational Journal of Colorectal Disease, 2015
- Iron‐deficiency anemia: A predictor of diminished disease‐free survival of T3N0M0 stage colon cancerJournal of Surgical Oncology, 2011
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- The Prevalence of Iron Deficiency Anemia and Its Clinical Implications in Patients with Colorectal CarcinomaJournal of the Chinese Medical Association, 2008